Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells.
Hooijkaas
H
H
Adriaansen
H J
HJ
van Dongen
J J
JJ
D000943:Antigens, Differentiation / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000134:cerebrospinal fluid*; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid* / Q000175:diagnosis / Q000473:pathology; D002452:Cell Count; D004253:DNA Nucleotidylexotransferase / Q000134:cerebrospinal fluid; D004273:DNA, Neoplasm / Q000134:cerebrospinal fluid; D015321:Gene Rearrangement; D006801:Humans; D007938:Leukemia / Q000134:cerebrospinal fluid* / Q000145:classification / Q000473:pathology; D008228:Lymphoma, Non-Hodgkin / Q000134:cerebrospinal fluid* / Q000145:classification / Q000473:pathology; D008577:Meningeal Neoplasms / Q000134:cerebrospinal fluid* / Q000175:diagnosis / Q000473:pathology; D009363:Neoplasm Proteins / Q000097:blood / Q000134:cerebrospinal fluid; D012334:RNA, Neoplasm / Q000134:cerebrospinal fluid
D000943:Antigens, Differentiation; D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D004253:DNA Nucleotidylexotransferase